Recruiting Clinical Trials
During the essential recruiting stage of a clinical trial, researchers attempt to identify and enroll participants. Recruitment activities may include various forms of advertising and other ways of soliciting interest from possible participants. However, this stage of a trial is increasingly difficult to complete well, as pharmaceutical industry stakes continue to intensify and add to the competition to find participants.
This stage of the trial represents one of the first, and arguably, most essential element to its success. Without gaining adequate enrollment, basic participant retention numbers may not be met, meaning the researchers may be left with too small a remaining participant pool to pull conclusive results either proving or disproving the trial goals of the sponsor. In order to develop an acceptable pool of enrolled participants, sound strategies for patient recruitment must be developed and carried out.
Successful investigator recruitment also hinges on this same adherence to sound strategies of recruitment. One past limitation to recruiting has been that pharmaceutical companies do not invest as heavily in marketing research and expertise when targeting a site, locating a trial there and communicating the value of it to patients. This has led to poor past recruiting results.
Therefore, better communication from pharmaceutical companies at this stage has allowed for the dramatic improvement in clinical trial success. Improving communications can result in more appropriately selected study sites, in addition to the all-important need for patients who will remain with a study to its completion, which ultimately saves time and money.